FibroBiologics Inc. (NASDAQ: FBLG)
$5.32
+0.3150 ( +6.30% ) 132.5K
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Market Data
Open
$5.32
Previous close
$5.00
Volume
132.5K
Market cap
$189.67M
Day range
$4.93 - $5.42
52 week range
$3.90 - $55.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 3 | Feb 15, 2024 |
8-k | 8K-related | 16 | Feb 14, 2024 |
3 | Insider transactions | 2 | Feb 13, 2024 |
3 | Insider transactions | 2 | Feb 13, 2024 |
3 | Insider transactions | 3 | Feb 08, 2024 |
3 | Insider transactions | 1 | Feb 08, 2024 |
8-k | 8K-related | 16 | Feb 08, 2024 |
3 | Insider transactions | 2 | Feb 07, 2024 |
3 | Insider transactions | 2 | Feb 07, 2024 |
3 | Insider transactions | 1 | Feb 07, 2024 |